BlackRock Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

BlackRock Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	444	–	–	﹤0.01%	3809
2016 Q3	$14K	Hold	444	–	–	﹤0.01%	3474
2016 Q2	$8K	Sell	444 -3,575	-89%	-$63.5K	﹤0.01%	3730
2016 Q1	$67K	Buy	4,019 +86	+2%	+$1.72K	﹤0.01%	3255
2015 Q4	$122K	Buy	3,933 +99	+3%	+$3.38K	﹤0.01%	3268
2015 Q3	$199K	Buy	3,834 +1,684	+78%	+$111K	﹤0.01%	3246
2015 Q2	$130K	Buy	+2,150	New	+$128K	﹤0.01%	3303

Other funds holding ALPN

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Investment Management's ALPN Position: Q4 2016 in Review

BlackRock Investment Management held its Alpine Immune Sciences Inc (ALPN) position steady in Q4 2016 at 444 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

BlackRock Investment Management first reported a position in ALPN in Q2 2015 and has held it in 7 quarters since. The position peaked at $199K in Q3 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

BlackRock Investment Management held 444 shares of Alpine Immune Sciences Inc worth $4K as of Q4 2016.
BlackRock Investment Management left its Alpine Immune Sciences Inc share count unchanged in Q4 2016.
Alpine Immune Sciences Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3809 holding.
BlackRock Investment Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Alpine Immune Sciences Inc position peaked at $199K in Q3 2015.
38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.